98%
921
2 minutes
20
Factors governing the clinical trajectory of Plasmodium falciparum infection remain an important area of investigation. Here we present transcriptomic, proteomic and metabolomic analyses comparing clinical subtypes of severe Plasmodium falciparum malaria to matched controls with uncomplicated disease in 79 children from Mali. MMP8, IL1R2, and ARG1 transcription is higher across cerebral malaria, severe malarial anemia, and concurrent cerebral malaria and severe malarial anemia, indicating a shared inflammatory signature. Tissue inhibitor of metalloproteinases 1 is the most upregulated protein in cerebral malaria, which along with elevated MMP8 and MMP9 transcription, underscores the importance of the metalloproteinase pathway in central nervous system pathophysiology. L-arginine metabolites are decreased in cerebral malaria, which coupled with increased ARG1 transcription suggests a putative mechanism impairing cerebral vasodilation. Using multi-omics approaches, we thus describe the inflammatory cascade in severe malaria syndromes, and identify potential therapeutic targets and biological markers.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC12086225 | PMC |
http://dx.doi.org/10.1038/s41467-025-59281-5 | DOI Listing |
J Int Med Res
September 2025
Department for Pathology, Chongqing General Hospital, China.
This case details a male patient in his late 50s weighing 90 kg who traveled to Burkina Faso, Africa, for approximately 1 month. He developed fever, headache, and generalized myalgia 3 days after returning to Chongqing, China. The interval from the emergence of the patient's symptoms to the diagnosis of severe falciparum malaria and the commencement of artesunate treatment was 9 days.
View Article and Find Full Text PDFCureus
August 2025
Infectious Diseases, Qazvin University of Medical Sciences, Qazvin, IRN.
Malaria is a potentially life-threatening parasitic disease caused by a protozoal infection via Plasmodium species, transmitted by a carrier female Anopheles mosquito. Cerebral malaria is typically caused by Plasmodium falciparum and is known as a fatal neurological complication of malaria. This systematic review and meta-analysis was performed due to limited research on the comparison of artemether and quinine for the treatment of cerebral malaria in children.
View Article and Find Full Text PDFPLoS One
September 2025
Department of Medical Sciences, School of Medicine, Walailak University, Nakhon Si Thammarat, Thailand.
Cerebral malaria (CM), a life-threatening consequence of Plasmodium falciparum infection, is associated with a high fatality rate and long-term brain impairment in survivors. Despite advances in malaria treatment, effective therapies to mitigate the severe neurological consequences of CM remain limited. Consequently, novel antimalarial drugs with different mechanisms or neuroprotective advantages are urgently required.
View Article and Find Full Text PDFJ Neuroinflammation
August 2025
Department of Immunology, College of Basic Medical Sciences, China Medical University, Shenyang City, Liaoning Province, 110122, P.R. China.
Cerebral malaria (CM) is the most severe complication of Plasmodium falciparum infection, and accounts for the majority of malaria-associated mortality. Reducing the overwhelming inflammatory responses in the early stage of infection is a key point to prevent death due to CM. In this study, we found that neutrophil mobilization occurred rapidly in response to Plasmodium berghei ANKA (PbA) infection in a murine CM model.
View Article and Find Full Text PDF